Melissa Joan Hart says her hot flashes and night sweats are severe enough to wake her from sleep, and that interruption has become the most disruptive part of menopause for her. The 50-year-old is now pairing that firsthand account with Bayer’s Life Doesn’t Stop for a Hot Flash campaign, which is drawing attention to a newer treatment option.
“These night sweats wake me up from my sleep, and that’s disruptive to my whole life, but it’s also just alarming when it happens,” she said. Hart added that when hot flashes hit, “they hit with a vengeance,” and that stopping sleep is what makes the symptom severe. She also said she wishes she had known more about the symptoms, the struggles and the options.
Bayer and Lynkuet
The campaign shines a light on Lynkuet, a newer FDA-approved, nonhormonal prescription medication developed by Bayer to treat moderate-to-severe hot flashes associated with menopause. For women weighing options, that label matters because it places the medication in the category reserved for symptoms that interfere with daily life, not just occasional discomfort.
Cory Rice described hot flashes as sudden feelings of intense heat that usually start in the chest, neck or face and can spread throughout the body. He said they can bring sweating, flushing, a racing heartbeat and occasionally chills afterward, then break them into mild, moderate and severe episodes; severe flashes can interrupt activities, affect concentration or wake a woman from sleep.
Hart’s sleep disruption
Diana Bitner said hot flashes can strike just about anytime, day or night, and can last for a long time. Hart’s experience fits that pattern closely: her most difficult symptom is not a passing wave of heat, but the way it cuts into sleep and rolls into the next day.
She said she grew up in a home where menopause was not talked about, which makes the partnership more than a promotional tie-in. “Until I partnered up with Bayer, I didn’t realize that there were treatment options,” she said, and that gap is the point of the campaign. Women who have been sleeping poorly because of night sweats are being shown that disruptive symptoms do not have to be brushed off as normal background noise.
What the campaign changes
Hart’s comments give the campaign a practical edge: it is not just asking women to notice hot flashes, but to recognize when sleep loss and daily disruption move symptoms into the moderate-to-severe range. Lynkuet is the option highlighted here, and the open question for readers is straightforward: how much relief it can offer once symptoms reach the point where a woman is waking up instead of sleeping through the night.
